Journal of Clinical Epidemiology
Volume 50, Issue 2 , Pages 185-193, February 1997

Long-term cost-effectiveness of alternative management strategies for patients with life-threatening ventricular arrhythmias☆☆☆

  • Mark A. Hlatky

      Affiliations

    • Corresponding Author InformationAddress for correspondence: and reprints: Mark Hlatky, M.D., Stanford University School of Medicine, HRP Redwood Building, Room 150, Stanford, CA 94305-5092.
    • Department of Health Research and Policy and Department of Medicine, Stanford University School of Medicine, Stanford, California 94305-5092 U.S.A.
    • ,
  • Derek B. Boothroyd

      Affiliations

    • Department of Health Research and Policy and Department of Medicine, Stanford University School of Medicine, Stanford, California 94305-5092 U.S.A.
    • ,
  • Iain M. Johnstone

      Affiliations

    • Department of Health Research and Policy and Department of Medicine, Stanford University School of Medicine, Stanford, California 94305-5092 U.S.A.
    • ,
  • Frank I. Marcus

      Affiliations

    • Department of Medicine, University of Arizona School of Medicine, Tucson, Arizona 85724 U.S.A.
    • ,
  • Elizabeth Hahn

      Affiliations

    • Department of Medicine, University of Arizona School of Medicine, Tucson, Arizona 85724 U.S.A.
    • ,
  • Vernon Hartz

      Affiliations

    • Department of Medicine, University of Arizona School of Medicine, Tucson, Arizona 85724 U.S.A.
    • ,
  • Jay W. Mason

      Affiliations

    • Department of Medicine, University of Utah School of Medicine, Salt lake City, Utah 84132 U.S.A.

Accepted 4 September 1996.

for the ESVEM Investigators

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Presented in part at the meeting of the American Federation for Clinical Research, May 1993. Refer to [5] which has an Appendix listing the ESVEM Investigators.

☆☆ Supported by a grant from Bristol-Meyers Squibb Company, Princeton, New Jersey, and Grant HL-34071 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. Additional support from Knoll Pharmaceuticals, Whippany, New Jersey; Boehringer-Ingleheim Corporation, Ridgefield, Connecticut; Ciba-Geigy Corporation, Summit, New Jersey; Grant RR-00064 from the National Center for Research Resources, Bethesda, Maryland; and the Robert Wood Johnson Foundation, Princeton, New Jersey.

PII: S0895-4356(96)00331-9

Journal of Clinical Epidemiology
Volume 50, Issue 2 , Pages 185-193, February 1997

Article Tools